Deprecated: Use of MediaWiki\Output\OutputPage::setIndexPolicy with index after noindex was deprecated in MediaWiki 1.43. [Called from MediaWiki\Output\OutputPage::setRobotPolicy in /home/forge/wikitrademarks.org/includes/Output/OutputPage.php at line 1008] in /home/forge/wikitrademarks.org/includes/debug/MWDebug.php on line 385
Category:Boris Reva of New York NY (US) - WikiTrademarks Jump to content

Category:Boris Reva of New York NY (US)

From WikiTrademarks
Revision as of 15:46, 21 July 2024 by Unknown user (talk) (Updating Category:Boris_Reva_of_New_York_NY_(US))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Boris Reva of New York NY (US)

Executive Summary

Boris Reva of New York NY (US) is an inventor who has filed 2 patents. Their primary areas of innovation include for computer-aided diagnosis, e.g. based on medical expert systems (2 patents), for cancer (2 patents), for cancer (2 patents), and they have worked with companies such as Icahn School of Medicine at Mount Sinai (2 patents). Their most frequent collaborators include (2 collaborations), (2 collaborations).

Patent Filing Activity

File:Boris Reva of New York NY (US) Monthly Patent Applications.png

Technology Areas

File:Boris Reva of New York NY (US) Top Technology Areas.png

List of Technology Areas

  • G16H50/20 (for computer-aided diagnosis, e.g. based on medical expert systems): 2 patents
  • G01N33/57442 (for cancer): 2 patents
  • G01N33/57449 (for cancer): 2 patents
  • G16H50/30 (for calculating health indices; for individual health risk assessment): 2 patents
  • G01N33/6854 ({Immunoglobulins}): 1 patents
  • G16B20/00 (ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations): 1 patents

Companies

File:Boris Reva of New York NY (US) Top Companies.png

List of Companies

  • Icahn School of Medicine at Mount Sinai: 2 patents

Collaborators

Subcategories

This category has the following 3 subcategories, out of 3 total.

Cookies help us deliver our services. By using our services, you agree to our use of cookies.